A conditional approval will still cause a price jump as the market is huge and $20-30 (depending on terms) is probable
In the CMA scenario, which terms do you think EMA is most likely to set? Broad vs subgroup label, confirmatory trial burden, and monitoring requirements could mean the difference between $20 or closer to $30.
Market Data 
Markets 
AI
